ESR1 and neoplasm: To examine potential cancer cell-specific adaptations in the in vivo tumor microenvironment of obese and non-obese patients, we obtained tumor tissue microarrays (TMA) from this group of PM/ER−/PR− patients and immunostained the cores for the stemness markers CD13316,17 and Axl18.